Association of genetic variation in serum amyloid-A with cardiovascular disease and interactions with IL6, IL1RN, IL1β and TNF genes in the cardiovascular health study

Journal of Atherosclerosis and Thrombosis

Volumn 16, Issue 4, 2009, Pages 419-430

  Carty, Cara L ^a   Heagerty, Patrick ^a   Heckbert, Susan R ^a   Enquobahrie, Daniel A ^a   Jarvik, Gail P ^a   Davis, Scott ^a   Tracy, Russell P ^b   Reiner, Alexander P ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Acute phase reactants; Carotid IMT; Genetic variants; Ischemic stroke; Myocardial infarction

Indexed keywords

AMYLOID A PROTEIN; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AFRICAN AMERICAN; AGED; ALLELE; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ACTIVITY; EUROPE; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; OBESITY; POPULATION GENETICS; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 73249146240     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.No968     Document Type: Article

References (45)

1. Upragarin N, Landman WJ, Gaastra W, Gruys E: Extrahepatic production of acute phase serum amyloid A. Histol Histopathol, 2005; 20: 1295-1307
2. Zhao Y, Zhou S, Heng CK: Impact of serum amyloid A on tissue factor and tissue factor pathway inhibitor expression and activity in endothelial cells. Arterioscler Thromb Vasc Biol, 2007; 27: 1645-1650
3. Jahangiri A, de Beer MC, Noffsinger V, Tannock LR, Ramaiah C, Webb NR, van der Westhuyzen DR, de Beer FC: HDL remodeling during the acute phase response. Arterioscler Thromb Vasc Biol, 2009; 29: 261-267
4. Uhlar CM, Whitehead AS: Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem, 1999; 265: 501-523
5. Schillinger M, Exner M, Mlekusch W, Sabeti S, Amighi J, Nikowitsch R, Timmel E, Kickinger B, Minar C, Pones M, Lalouschek W, Rumpold H, Maurer G, Wagner O, Minar E: Inflammation and Carotid Artery-Risk for Atherosclerosis study (ICARAS). Circulation, 2005; 111: 2203-2209
6. Fyfe AI, Rothenberg LS, DeBeer FC, Cantor RM, Rotter JI, Lusis AJ: Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes. Circulation, 1997; 96: 2914-2919
7. Johnson BD, Kip KE, Marroquin OC, Ridker PM, Kelsey SF, Shaw LJ, Pepine CJ, Sharaf B, Bairey Merz CN, Sopko G, Olson MB, Reis SE; National Heart, Lung, and Blood Institute. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation, 2004; 109: 726-732
8. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB: Low grade inflammation and coronary heart disease: Prospective study and updated meta-analyses. BMJ, 2000; 321: 199-204
9. Chait A, Han CY, Oram JF, Heinecke JW: Thematic review series: The immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease. J Lipid Res, 2005; 46: 389-403
10. MacGregor AJ, Gallimore JR, Spector TD, Pepys MB: Genetic effects on baseline values of C-reactive protein and serum amyloid a protein: a comparison of monozygotic and dizygotic twins. Clin Chem, 2004; 50: 130-134
11. Whitehead AS, de Beer MC, Steel DM, Rits M, Lelias JM, Lane WS, de Beer FC: Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein. J Biol Chem, 1992; 267: 3862-3867
12. Candore G, Vasto S, Colonna-Romano G, Lio D, Caruso M, Rea IM, Caruso C. Atherosclerosis. In: Vandenbroeck K, editor. Cytokine Gene Polymorphisms in Multifactorial Diseases. Boca Raton, FL: CRC Press, Taylor & Francis Group, 2006
13. Baba S, Masago SA, Takahashi T, Kasama T, Sugimura H, Tsugane S, Tsutsui Y, Shirasawa H: A novel allelic variant of serum amyloid A, SAA 1 gamma: Genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic a-amyloidosis. Hum Mol Genet, 1995; 4: 1083-1087
14. Kooperberg C, Ruczinski I, LeBlanc ML, Hsu L: Sequence analysis using logic regression. Genet Epidemiol, 2001; 21 Suppl 1: S626-S631
15. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, O'Leary DH, Psaty B, Rautaharju P, Tracy RT, Weiler PG: The Cardiovascular Health Study: design and rationale. Ann Epidemiol, 1991; 1: 263-276
16. Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP: Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem, 1995; 41: 264-270
17. Macy EM, Hayes TE, Tracy RP: Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem, 1997; 43: 52-58
18. O'Leary DH, Polak JF, Wolfson SK Jr, Bond MG, Bommer W, Sheth S, Psaty BM, Sharrett AR, Manolio TA: Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke, 1991; 22: 1155-1163
19. Ives DG, Fitzpatrick AL, Bild DE, Psaty BM, Kuller LH, Crowley PM, Cruise RG, Theroux S: Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol, 1995; 5: 278-285
20. SeattleSNPs. NHLBI program for genomic applications, Seattle SNPs, Seattle, WA. (URL: http://pga.gs.washington.edu/), Accessed September 2006
21. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA: Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet, 2004; 74: 106-120
22. Reiner AP, Ziv E, Lind DL, Nievergelt CM, Schork NJ, Cummings SR, Phong A, Burchard EG, Harris TB, Psaty BM, Kwok PY: Population structure, admixture, and aging-related phenotypes in African American adults: The Cardiovascular Health Study. Am J Hum Genet, 2005; 76: 463-477
23. Whitesitt JE. Boolean algebra and its applications. Mineola, N.Y. : Dover Publications, 1995
24. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K: dbSNP: the NCBI database of genetic variation. Nucleic Acids Res, 2001; 29: 308-311
25. Carty CL, Heagerty P, Nakayama K, McClung EC, Lewis J, Lum D, Boespflug E, McCloud-Gehring C, Soleimani BR, Ranchalis J, Bacus TJ, Furlong CE, Jarvik GP: Inflammatory response after influenza vaccination in men with and without carotid artery disease. Arterioscler Thromb Vasc Biol, 2006; 26: 2738-2744
26. Elkind MS, Cole JW: Do common infections cause stroke ? Semin Neurol, 2006; 26: 88-99
27. Chambless LE, Folsom AR, Clegg LX, Sharrett AR, Shahar E, Nieto FJ, Rosamond WD, Evans G: Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol, 2000; 151: 478-487
28. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX: Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) study, 1987-1993. Am J Epidemiol, 1997; 146: 483-494
29. Wohlin M, Helmersson J, Sundström J, Arnlöv J, Vessby B, Larsson A, Andrén B, Lind L, Basu S: Both cyclooxygenase-and cytokine-mediated inflammation are associated with carotid intima-media thickness. Cytokine, 2007; 38: 130-136
30. Walston JD, Fallin MD, Cushman M, Lange L, Psaty B, Jenny N, Browner W, Tracy R, Durda P, Reiner A: IL-6 gene variation is associated with IL-6 and C-reactive protein levels but not cardiovascular outcomes in the Cardiovascular Health Study. Hum Genet, 2007; 122: 485-494
31. Lange LA, Carlson CS, Hindorff LA, Lange EM, Walston J, Durda JP, Cushman M, Bis JC, Zeng D, Lin D, Kuller LH, Nickerson DA, Psaty BM, Tracy RP, Reiner AP: Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA, 2006; 296: 2703-2711
32. Rauramaa R, Väisänen SB, Luong LA, Schmidt-Trücksäss A, Penttilä IM, Bouchard C, Töyry J, Humphries SE: Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol, 2000; 20: 2657-2662
33. Abe-Dohmae S, Kato KH, Kumon Y, Hu W, Ishigami H, Iwamoto N, Okazaki M, Wu CA, Tsujita M, Ueda K, Yokoyama S: Serum amyloid A generates high density lipoprotein with cellular lipid in an ABCA1-or ABCA7-dependent manner. J Lipid Res, 2006; 47: 1542-1550
34. Kluve-Beckerman B, Dwulet FE, Benson MD: Human serum amyloid a. Three hepatic mRNAs and the corresponding proteins in one person. J Clin Invest, 1988; 82: 1670-1675
35. Strachan AF, de Beer FC, van der Westhuyzen DR, Coetzee GA: Identification of three isoform patterns of human serum amyloid A protein. Biochem J, 1988; 250: 203-207
36. Wang L, Colón W: The interaction between apolipoprotein serum amyloid A and high-density lipoprotein. Biochem Biophys Res Commun, 2004; 317: 157-161
37. Xu Y, Yamada T, Satoh T, Okuda Y: Measurement of serum amyloid A1 (SAA 1), a major isotype of acute phase SAA. Clin Chem Lab Med, 2006; 44: 59-63
38. Johnson BA, Fram EK, Dayer BP, Dean BL, Keller PJ, Jacobowitz R: Evaluation of shared-view acquisition using repeated echoes (SHARE): A dual-echo fast spin-echo MR technique. AJNR Am J Neuroradiol, 1994; 15: 667-673
39. Morrison AC, Bare LA, Chambless LE, Ellis SG, Malloy M, Kane JP, Pankow JS, Devlin JJ, Willerson JT, Boerwinkle E: Prediction of coronary heart disease risk using a genetic risk score: The Atherosclerosis Risk in Communities study. Am J Epidemiol, 2007; 166: 28-35
40. Hagihara K, Nishikawa T, Isobe T, Song J, Sugamata Y, Yoshizaki K: Il-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system. Biochem Biophys Res Commun, 2004; 314: 363-369
41. Reiner AP, Wurfel MM, Lange LA, Carlson CS, Nord AS, Carty CL, Rieder MJ, Desmarais C, Jenny NS, Iribarren C, Walston JD, Williams OD, Nickerson DA, Jarvik GP: Polymorphisms of the il1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation. Arterioscler Thromb Vasc Biol, 2008; 28: 1407-1412
42. Arend WP: The balance between IL-1 and IL-1Ra in disease. Cytokine & Growth Factor Reviews, 2002; 13: 323-340
43. González S, Rodrigo L, Martínez-Borra J, López-Vázquez A, Fuentes D, Niño P, Cadahía V, Saro C, Dieguez MA, López-Lárrea C: TNF-alpha-308a promoter polymorphism is associated with enhanced TNF-alpha production and inflammatory activity in Crohn's patients with fistulizing disease. Am J Gastroenterol, 2003; 98: 1101-1106
44. Choudhury L, Marsh JD: Myocardial infarction in young patients. Am J Med, 1999; 107: 254-261
45. Carr FJ, McBride MW, Carswell HV, Graham D, Strahorn P, Clark JS, Charchar FJ, Dominiczak AF: Genetic aspects of stroke: human and experimental studies. J Cereb Blood Flow Metab, 2002; 22: 767-773